These compounds may interact with:
N-formyl peptide receptor 2
Potentially involved in: carcinoma; alzheimer's disease; secondary progressive multiple sclerosis; crohn disease; colon cancer; hepatocellular carcinoma; lung adenocarcinoma; lung cancer; lung carcinoma; mucosa-associated lymphoid tissue lymphoma; multiple sclerosis; non-small cell lung cancer; psoriasis; ulcerative colitis
Disease data sourced from Pharos.